Picture of Standard Chem & Pharm Co logo

1720 Standard Chem & Pharm Co Income Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Annual income statement for Standard Chem & Pharm Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3,9374,3054,6045,8516,240
Cost of Revenue
Gross Profit1,7091,9202,0682,4882,725
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses3,4213,5993,7294,7334,937
Operating Profit5167078751,1181,302
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5867731,0141,4001,438
Provision for Income Taxes
Net Income After Taxes4706268371,1541,158
Minority Interest
Net Income Before Extraordinary Items
Net Income376524707815835
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income376524707815835
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.152.933.624.594.47
Dividends per Share